InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by BISCHOFBERGER NORBERT W, Chairman & CEO. Officer active across 1 company, notably Kronos Bio, Inc.. Cumulatively, 3 disclosures have been published. Split: 3 buys · 0 sell. Total volume traded: €637k. Activity tracked since 6 December 2021. The latest transaction was filed on 17 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
90,931 shares@ US$3.832951.8% of flowCommon StockSEC:0001209191-22-030688:0
Ideal exit: 11 Feb 2023 (T+270)
14,356 shares@ US$12.08524.1% of flowCommon StockSEC:0001209191-21-068594:0
Ideal exit: 2 Sept 2022 (T+270)
14,356 shares@ US$12.085100.0% of flowCommon StockSEC:0001209191-21-068594
Ideal exit: 2 Sept 2022 (T+270)
3 of 3 declarations
About BISCHOFBERGER NORBERT W
Norbert W. Bischofberger is the Chairman & CEO of Kronos Bio, Inc. He leads the company with a strategic vision focused on innovation in the biotechnology sector. His role involves overseeing operations and developing new initiatives to strengthen the company's market position. Bischofberger brings valuable expertise and informed leadership to the executive team.
